Astell and AstellBio at Medlab Middle East 2023 and ChemUK 2023

Astell – the leading manufacturer of autoclaves in the UK, and their sister company AstellBio – the thermal effluent decontamination systems company, will be exhibiting at Medlab Middle East 2023 between the 6th and 9th of February, in Dubai, United Arab Emirates.

The companies are aiming to bring their expertise to a wider audience of laboratories across multiple sectors, including research, pharmaceutical, and healthcare both in the Middle East and across the world. And with AstellBio having recently released a range of small liquid waste autoclaves designed to enhance laboratory safety, the multinational event provides an excellent opportunity to introduce this whole new type of autoclave to the region.

Closer to home, AstellBio will be exhibiting at their inaugural solo trade show in May – ChemUK. The company hopes that its new range of liquid waste autoclaves will find an audience with ChemUK’s new CHEMLAB show, while their larger effluent decontamination systems will be of interest to businesses who have traditionally used chemical methods to sterilise their wastewater.

“In 2023 we want to make sure everyone is aware of our cleaner, safer ways to decontaminate and dispose of biologically contaminated liquid waste, and these free-to-attend events are an excellent chance to do so,” said Astell & AstellBio’s Sales and Marketing Director, Paul Birchmore. “Our latest range of small liquid waste autoclaves provides the biopharmaceutical research laboratory with the same thermal wastewater treatment technology that our large-scale effluent decontamination systems have provided to the wider pharmaceutical sector.”

Astell and AstellBio will be exhibiting on Booth Z2.L18 at Medlab Middle East 2023, 6th to 9th February 2023.

AstellBio will be exhibiting on Booth C74 at ChemUK 2023, 10th to 11th May 2023.

A message from the Editor:

Thank you for reading this story on our news site - please take a moment to read this important message:

As you know, our aim is to bring you, the reader, an editorially led news site but journalism costs money and we rely on advertising and digital revenues to help to support them.

With the Covid-19 lockdown having a major impact on our industry as a whole, the advertising revenues we normally receive, which helps us cover the cost of our journalists and this website, have been drastically affected.

As such we need your help. If you can support our news sites with a small donation of even £1, your generosity will help us weather the storm and continue in our quest to deliver quality journalism.

In the meantime may I wish you the very best.

- Advertisement -

Related news